Ledger.Open graph →
SEC Form D · filed September 6, 2018

Olaregen Therapeutix Inc

Offering
$1.2M
Sold
$450K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Scott Emmens · New York, NYExecWesley Ramjeet · Edison, NJExec · DirectorAnthony Dolisi · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗